The female sex hormone, oestrogen, plays a central role in breast cell proliferation in both the normal and malignant state. It controls transcription from several genes, including that for the progesterone receptor, and in endometrial tissue, via this receptor, it controls the gene for the enzyme oestrogen sulfotransferase. This enzyme may control the level of the oestrogen receptor by sulfurylating free oestradiol. To study the mode of transcriptional control exercised by oestrogen, bovine oestrogen sulfotransferase cDNA has been cloned and the nucleotide sequence determined. The message, of which 1812 bases have been sequenced, contains an open reading frame of 885 bases which encode a protein of 295 amino acids and a maximum apparent molecular weight of 34 600. The deduced protein sequence is supported by existing peptide sequence data and appears to contain a steroid-binding region. Some physico-chemical characteristics of the enzyme appear to differ markedly from those previously reported.
Introduction
Oestrogen sulfotransferase (OST, Ee 2.8.2.4) is an intracellular enzyme present in most human foetal tissues (Wengle 1966) , but it has a more limited distribution in adult tissues (Bostrom and Wengle 1967; Pack et al. 1979; Tseng et al. 1985) . It has been detected in some breast carcinomas (Adams 1964) and in these tumours the activity of the enzyme appears to correlate with the concentration of oestrogen receptors. It has been proposed that the level of enzyme activity may constitute an independent prognostic variable in breast cancer Tseng et al. 1983) . A role for the enzyme in this disease has yet to be described.
Similarly, nothing is known of the transcriptional control of the OST gene in breast cancer. However, in human endometrium progesterone appears to induce transcription of the gene (Pewnin et al. 1980) , while transcription from the progesterone receptor gene is controlled by the oestrogen receptor (Leavitt et al. 1978) with oestrogen sulfotransferase contributing to the control of the level of oestrogen (reviewed by Hobkirk 1985) . While it is reasonable to expect that this system may operate in hormone-dependent breast cancers, i.e. those with an absolute requirement for oestrogen for growth, it would appear unlikely that the same system could exist in those cancers which are hormone-independent and which constitute the majority of human breast cancers (65%).
To define a role for OST in human breast cancer, and as part of a larger program of study of the control of expression of genes for steroid-binding proteins, OST was isolated from bovine placental tissue (Moore et al. 1988 ) using modifications of the method of 0004-9417/88/040507$03.00 . The enzyme appeared to have a monomeric molecular weight of around 36 000 although there was some evidence that the active form of the enzyme could be a dimer with a molecular weight of 72 000. Peptides from the OST preparation were sequenced and the sequences used to design oligonucleotide probes. In the study reported the base sequence of the entire message for the enzyme was determined.
Materials and Methods
All common chemicals and solvents were AR grade. All isotopes were obtained from Amersham (Australia) Pty Ltd. Unless otherwise indicated enzymes were from Promega Pty Ltd (Madison, WI., U.S.A.) or Pharmacia (Australia) Pty Ltd, all electrophoresis reagents and equipment were from Bio Rad (Sydney, Australia) and all common chemicals were from Sigma Chemical Company (St Louis, MO., U.S.A.).
Construction of cDNA Library
Bovine placentas were collected fresh from the abattoirs and stored at -70°C. Frozen tissue was homogenised in 3-4 volumes of 7 M guanidine hydrochioride/IO mM Tris/IO mM EDTA/5% (3-mercaptoethanol, pH 7·5, after which cesium chloride (CsCl) and sodium sarkosyl were added to concentrations of 40% (w/v) + O· 5% (v/v) respectively. The homogenate was layered onto a 20 mm cushion of 5·7 M CsCI in 0·1 M EDTA, pH 7·5, in a 16 mm x 100 mm polyallomer tube and centrifuged at 100000 g for 16 h at 20°C. Further purification of the total RNA and selection of poly(A) + RNA on oligo(dT) columns was according to the methods described by Maniatis et af. (1982) .
First strand cDNA synthesis, using mixed primers, was performed with a Reverse Transcriptase System kit from New England Nuclear (Boston, MA., U.S.A.). Second strand synthesis, with hairpin loop self priming, was performed using the same kit. Hairpin loop hydrolysis with SI nuclease and purification of the cDNA was according to Maniatis et af. (1982) . Eco Rl sites were methylated and linkers added according to the methods described by Grubler and Hoffman (1983) . 'Cold' or 'hot'linkers were generated by phosphorylation of the 5' end of the oligonucleotide with either ATP or [-y_ 32 p] ATP (Wu et af. 1987) . Excess linkers were removed from the ligation mixture by passage over a NACS column (B. R. L. Gaithersburg, MD., U.S.A.).
The cDNA was ligated into A gtll arms using the Promega 'Protocione GT' system and packaged using the Promega 'Packagene' system. The library was amplified in E. coli Y1090.
Probe Construction
Oligonucleotide probes were synthesised using a Model 380A Automatic DNA Synthesiser (Applied Biosystems Inc., Australia) and the protocols recommended by this company. Non-degenerate probes were derived directly from cDNA sequences already determined while the base sequences of degenerate probes were based on the amino acid sequences of peptides derived from a tryptic digest of the purified enzyme (Moore et af. 1988) . The methods of Lathe (1985) were utilised to minimise the degeneracy of these probes.
Screening the Library
The A gtll library was plated out in E. coli Y1090 on 150 mm diameter petri dishes at a phage concentration slightly lower than that required to produce confluent lysis. Transfer of plaques to nitrocellulose filters, hybridisation to the labelled probe, purification of positive plaques and the preparation of plate lysate stocks were essentially as described by Maniatis et af. (1982) .
Cfone Sequencing
Insert DNA from individual clones was subcloned into the vector Ml3tg 130/131 by the method of Kieny et af. (1983) . The di-deoxy chain termination sequencing method of Sanger et af. (1977) was used in conjunction with the [a 35 S] ATP modification suggested by Biggin et af. (1983) . Nucleotide and amino acid sequences were compared by use of the MBIS system (Reisner and Bucholtz 1986) which utilises the SEQH and SEQHP programs of Kanehisa et af. (1984) . The statistical significance of an alignment was tested, within these programs, by comparing it with the alignments of 20 random sequences. The SWISS-PROT protein database used was accessed via the Commonwealth Scientific and Industrial Research Organisation's Molecular Biology Information Service (Canberra, Australia).
Sequencing Strategies
Degenerate probes derived from the sequence of tryptic peptides were used to isolate major clones. Once the base sequences of these clones had been established non-degenerate probes complementary to the terminal sequences of these major clones were synthesised. These probes were used to extend the sequences in the 5' or 3' direction, or to provide overlap sequences between major clones. Table 1 . Oligonucleotide probe sequences Peptides were purified from a tryptic digest of bovine OST (Moore et al. 1988) . For probes 1-3 the probe sequence was derived from the peptide sequence; degeneracy was minimised by utilisation of codon usage tables and the known instability of C-G base sequences when C is the third codon position. Probes 4-6 were synthesised as the nondegenerate complements of cDNA sequences established earlier in the study. All probes were synthesised using an Applied Biosystems 380A automatic DNA synthesiser and the protocols recommended by the company. In probe 1 inosine was inserted at the positions marked'!,. Degenerate codons are shown with the alternative nucleotide below the third position in probes 1-3. Peptides are shown N-terminus to C-terminus and probes are 
Based on known cDNA sequence ATCACTTCAGAGTGGACGGACACTTCGAAGAAGG Based on known cDNA sequence GACATTTCAAAATTACTTACACTGTATATGGTCA Based on known cDNA sequence CAAACCCTGAGAAAGGACTAACCTGAGTCTGACG
The base sequences of the probes used in this study are shown in Table 1 . Also shown are the peptide sequences from which they were derived. The base sequences of probes 4-6 were derived from cDNA sequences of clones isolated with probes 2 and 3.
On a Northern blot (Thomas 1980) of the total mRNA a single size species hybridised to probe 1 and this species was in the range 1· 5 kb-3' 0 kb (Fig. 1) . The size for the message was confirmed when total mRNA was subjected to sucrose density centrifugation. A single species in the fraction sedimenting between 16S and 23S bound to probe 4.
The A gtll library contained 10 5 recombinants. Screening of this library with probe 1 was unsatisfactory as the probe hybridised to all recombinants. Using the SEQH program strong homologies were found between the probe sequence and several stretches of sequence from the lambda genome, e.g. 16 out of the 24 bases of the probe are identical to the sequence from position 42484 to position 42507 of the lambda genome. Therefore, the longer probes (2-6) were used in the isolation of OST cDNA inserts, none of which were larger than 582 bp. The spatial relationship between the cDNA clones sequenced in this study is conditions. Following electrophoresis the RNA was transferred to nitrocellulose paper by the Northern blotting technique. The transferred RNA was hybridised to the end-labelled probe 1 (Table 1) Assuming trypsin will not cleave the K-P bond between residues 5 and 6, and ignoring the single basic residue liberated by cleavage after successive basic residues, e.g. residues 22 and 23, there are 34 possible tryptic peptides. The boxed amino-acid sequences represent those tryptic peptides for which sequences were determined during an earlier study (Moore et al. 1988) and they are numbered according to their position in the linear array of the 34 peptides. The boxed nucleotide sequences mark the probe hybridisation sites. ' Fig. 2 . Although clones OST 2 and OST 4 were the first to be sequenced, for ease of explanation the results of clone detection and sequencing are presented in the linear order shown in Fig. 2 , not the temporal order in which the clones were isolated.
Probe 6 was a non-degenerate probe derived from the first 34 bases of clone OST 2. After use of this probe, re-analysis of the base sequence of clone OST 2 revealed that the putative single bases at positions 51(A) and 55(C) (Fig. 3) , were, in fact, doublets and the probe sequence beyond position 24 (Table 1) was no longer complementary to the cDNA sequence. Despite this, the probe was used successfully to isolate two clones. Clone OST la extended from position 1 to position 299. Clone OST Ib spanned positions 1-76 but differed in sequence from OST la in nine of the first 18 bases of the molecule as follows:
OST la CTTCCCCTCCACAGGTGA----OST Ib AAGCCACACCTCTGGAGG----However, in the absence of additional sequence data from this region, and in view of the results obtained by Richards et at. (1979) , it seems likely that these differences arose as artefacts of cloning.
Probe 2 was used to isolate eight clones of which five were unique. Clone OST 2 was sequenced and found to be 472 bp long. This clone overlapped with clone OST 1 at position Table 2 . Amino acid composition of oestrogen sulphotransferase deduced from the cDNA nucleotide sequence The amino acid composition deduced from the cDNA nucleotide sequence given in Figure 3 is shown for comparison with that obtained by direct analysis of the enzyme preparation of highest specific activity from which peptides for probe construction were isolated (Moore et at. 1988 Mol. wt 34600
A Including methionine at initiation site.
24 and extended to position 496. All other clones detected with probe 2 were contained within OST 2. Probe 4 was a non-degenerate probe based on the sequence of the first 34 bases of clone OST 4. It hybridised to a single cDNA species, clone OST 3, of 153 bp, which extended from position 465 to position 617 and provided the overlap between the major clones OST 2 and OST 4.
Probe 3 was used to isolate two clones. Clone OST 4 overlapped with OST 3 at position 523 and extended the sequence to position 1105. The second clone, OST 5, overlapped with OST 4 at position 993 and extended the sequence to position 1812. Although the library was screened with probes from each end of the cDNA (probes 5 and 6) no full length cDNA clone was detected. The library appeared to contain only shorter cDNA fragments. The complete cDNA sequence is shown in Fig. 3 .
A terminating codon was present at nucleotide position 156 and there were codons for methionine at nucleotide positions 213 and 270. However, the initiation site was assumed to be position 213 as the methionine coded for at position 270 was contained within a peptide (Tp2) isolated from a tryptic digest of the enzyme (Moore et at. 1988) . There were termination codons at nucleotide positions 1098 and 1113 and polyadenylation signals at nucleotide positions 1516 and 1798. Potential cAMP-dependent kinase phosphorylation sites were identified at positions 848 and 885 although no phosphate groups were found on the protein.
The amino acid sequence of the enzyme, deduced from the nucleotide sequence of the open reading frame of the message, also is shown in Fig. 3 . The alignments, with this sequence, of the tryptic peptides isolated in the earlier study (Moore et at. 1988) The amino acid composition of the enzyme, predicted from the cDNA sequence, is presented in Table 2 for comparison with the composition found by amino-acid analysis of material from the enzyme preparation of Moore et at. (1988 In Fig. 4 is shown the putative homology between the predicted sequences of the human oestrogen receptor (ER) and the bovine oestrogen sulfotransferase. This alignment was obtained by use of the SEQHP program which introduced spaces into both sequences to maximise the homology. The alignment shown is statistically significant (P = 0·04).
Discussion
Apart from the very high sulfotransferase activity of the preparation used in this study the data present in Fig. 4 suggest an oestrogen binding role for the protein studied. In the human oestrogen receptor the ligand-binding domain extends from residue 315 to 550 (Petkovich et af. 1987) . Between the oestrogen receptor and other human steroid receptors there are significant homologies in this region, e.g. 26% (641243) of residues can be aligned with the progesterone receptor and 28% (681243) of residues with the glucocorticoid receptor. When phylogenetic distances and different molecular functions are taken into consideration the alignment of 16% (361220) of residues from the bovine enzyme cDNA sequence with that of the human receptor sequence possibly defines the steroid-binding domain of the oestrogen sulfotransferase. A further similarity between the human receptor (Green et af. 1986 ) and the bovine enzyme is the presence in both of two potential phosphorylation sites; in the enzyme they are located at residues 213 (-RKAS-) and 225 (-KHTS-).
Earlier claims (Adams and Ellyard 1971; Clarke et af. 1982 ) that oestrogen sulfotransferase was structurally similar to serum albumin, and possibly shared a common genetic ancestor, cannot be sustained. Computer assisted comparisons of the primary structures of bovine serum albumin and bovine OST provided no evidence of albumin-like 'domains' in the primary structure of the enzyme and the sequence around none of the 35 half-cystine residues in bovine serum albumin bore any resemblance to the sequences around the four half-cystine residues found in bovine OST.
The cDNA sequence in Fig. 4 is that of a protein with a maximum molecular weight of 34600. Peptide Tpl (residues 1-14) was neither sought nor found so the N-terminal residue of the enzyme has not been defined. There is some evidence that it is blocked, possibly at a serine residue; no N-terminal amino acid could be detected when sequencing of the intact protein was attempted. The peptide, Tp2, was found and sequenced (Fig. 3) so the protein can be no shorter than 281 residues. Post-translational loss of part or all of the N-terminal peptide (Tpl) would yield a protein with a molecular weight in the range 33000-34600. Earlier estimates of the molecular weight of this enzyme as 72 000 (Adams et af. 1974 , Clarke et af. 1982 ) must be revised. Similar revision must be made of claims (Clarke et af. 1982) that the presence of lower molecular weight species in enzyme preparations could be attributed to proteolytic cleavage of a larger molecule.
Chromatographically, on Sephacryl S300, and electrophoretically, in non-denaturing conditions, the enzyme behaves as a molecule with an apparent molecular weight of around 70000 (Moore et af. 1988) . Since only one cDNA species was detected it would seem that the native, active enzyme is a dimer of identical 33000-34600 monomers. This is not dissimilar to the putative structure of another sulfotransferase, dehydroepiandrosterone sulfotransferase, which is a dimer of apparently identical monomers of molecular weight 34500 (Adams and McDonald 1979) .
The peptides used in this study were isolated from an enzyme preparation which contained a minor contaminant with a molecular weight of approximately 50000. The presence of this contaminant is reflected in the disparity of the amino acid compositions shown in Table 2 . It seems likely that the earlier workers co-purified, with their enzyme activity, major contaminating proteins with apparent molecular weights of around 70000. The presence of these contaminants in an enzyme preparation would provide an explanation for the previous reports of OST isoenzymes of low activity and high molecular weight which had superficial similarities to bovine serum albumin. gratefully acknowledged. This study was supported in part by the Australian Research Grants Scheme and the N.S.W. Cancer Council.
